University of Texas Health Science Center at Houston, Houston.
University of Texas Health Science Center at Houston, Houston 2Facial Plastic Surgery Associates, Houston, Texas.
JAMA Facial Plast Surg. 2016 Jul 1;18(4):305-11. doi: 10.1001/jamafacial.2016.0249.
Rhinoplasty is known to be one of the more technically challenging cosmetic procedures, with a revision rate of 5% to 15%. Reasons for revisions may range from minor deformities that can be treated in the office to major cosmetic and functional defects that require multiple surgical procedures to correct. The literature lacks a uniform scale that systematically evaluates the patient presenting for revision rhinoplasty. The TNM staging system for classifying malignant tumors was developed to aid the physician in planning treatment, providing some information about prognosis, assisting in evaluating the results of treatment, and facilitating the exchange of information. Although the patient presenting for a revision rhinoplasty does not have a potentially lethal disease, a classification system for such patients resembling that used for malignant tumors may provide similar benefits.
As in TNM staging, we describe 3 major components that determine the overall difficulty of surgery for revision rhinoplasty. In our PGS system, "P" represents "problem," consisting of the specific anatomic anomaly with which the patient presents. The second component in our system is "G" for "graft," based on the number of grafts required. The third component of this system is "S," for "number of previous surgical procedures." In addition, we have included a category "E," for "patient expectations," which is added after the stage of the patient's condition has been determined through the PGS classification.
Rather than being measured in terms of survival, as with the TNM system for malignant tumors, the prognosis in revision rhinoplasty is measured in terms of what can be achieved with surgery as opposed to what cannot. This preoperative staging system may help the patient understand the complexity of the repair required and help manage expectations. The PGS system will facilitate exchange of information between surgeons who perform revision rhinoplasty. A standardized evaluation system will allow meaningful comparisons of surgical techniques and evaluations of outcomes of rhinoplasty procedures.
众所周知,鼻整形术是一种技术要求较高的美容手术,其返修率为 5%至 15%。返修的原因可能从可以在办公室治疗的轻微畸形到需要多次手术矫正的严重美容和功能缺陷。文献中缺乏一种系统评估接受修复性鼻整形术的患者的统一标准。TNM 分期系统是为了帮助医生制定治疗计划而开发的,提供了一些关于预后的信息,有助于评估治疗结果,并促进信息交流。虽然接受修复性鼻整形术的患者没有潜在的致命疾病,但为这类患者制定类似于恶性肿瘤的分类系统可能会提供类似的益处。
与 TNM 分期一样,我们描述了决定修复性鼻整形术整体手术难度的 3 个主要因素。在我们的 PGS 系统中,“P”代表“问题”,由患者所呈现的特定解剖异常组成。我们系统中的第二个组成部分是“G”,代表“移植物”,基于所需移植物的数量。该系统的第三个组成部分是“S”,代表“先前手术的次数”。此外,我们还包括了一个“E”类别,代表“患者期望”,这是在通过 PGS 分类确定患者病情的阶段后添加的。
与用于恶性肿瘤的 TNM 系统不同,修复性鼻整形术的预后不是用生存来衡量,而是用手术可以达到的效果与不能达到的效果来衡量。这种术前分期系统可以帮助患者了解所需修复的复杂性,并帮助管理预期。PGS 系统将有助于进行修复性鼻整形术的外科医生之间的信息交流。标准化的评估系统将允许对鼻整形手术技术进行有意义的比较和对手术结果进行评估。